Lymphokine-activated killer (LAK) cells: I. Age-dependent decline of LAK cell-mediated cytotoxicity

This publication has 31 references indexed in Scilit:

• Cancer Immunotherapy Using Interleukin-2 and Interleukin-2-Activated Lymphocytes
  Annual Review of Immunology, 1986
• Dietary fat alters progression of some age-related changes of the immune system
  Immunology Letters, 1986
• Changes in lymphoma development in female SJL/J mice as a function of the ratio in low polyunsaturated/high polyunsaturated fat diet
  Cancer Letters, 1986
• Observations on the Systemic Administration of Autologous Lymphokine-Activated Killer Cells and Recombinant Interleukin-2 to Patients with Metastatic Cancer
  New England Journal of Medicine, 1985
• Strain-dependence and cellular aspects of the acceleration of age-dependent shift in class-specific helper and suppressor activity in the thymus of MRL/Mp mice by the LPR gene
  Cellular Immunology, 1985
• Regression of established pulmonary metastases and subcutaneous tumor mediated by the systemic administration of high-dose recombinant interleukin 2.
  The Journal of Experimental Medicine, 1985
• Lymphokine-activated killer (LAK) cells. Analysis of factors relevant to the immunotherapy of human cancer
  Cancer, 1985
• Accelerated development of a Th-2 type factor in animals with and without an imbalance between help and suppression
  Cellular and Molecular Life Sciences, 1982
• Mechanisms Involved in Age‐dependent Decline of Immune Responsiveness and Apparent Resistance against Tolerance Induction in C57BL/6 Mice
  Scandinavian Journal of Immunology, 1982
• Established cell line of urinary bladder carcinoma (T24) containing tumour‐specific antigen
  International Journal of Cancer, 1973